OncLive

Education ▼

Register | Login

Conference Coverage

Attend An Event

State of the Science Summit

Regional Seminar Series

OncLive Global Expo

Giants of Cancer Care

Join Our Community

Don't miss real-time top news, insights, and interviews with the experts direct from the conference floor in Chicago. Sign up now to be reminded to tune in to OncLive News Network: On Location in Chicago.

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Multiple Myeloma

Immuno-Oncology News

Gynecologic Oncology

Gastrointestinal Cancer

Colorectal Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

<< View More Conferences

2018 State of the Science Summit on Hematologic Malignancies in Cleveland

Oncology Conference Multimedia

View more videos >>

Dr. Dean on the Evolution of Treatment Approaches in MCL

Dr. Dean on the Evolution of Treatment Approaches in MCL

Dr. Valent on MRD Negativity in Multiple Myeloma

Dr. Valent on MRD Negativity in Multiple Myeloma

Dr. Carraway on Predisposition to Acute Myeloid Leukemia

Dr. Carraway on Predisposition to Acute Myeloid Leukemia

Oncology Conference Articles

Targeted Agents Beyond Ruxolitinib Necessary in Evolving MPN Paradigm

Targeted Agents Beyond Ruxolitinib Necessary in Evolving MPN Paradigm

Aaron Gerds, MD, discusses the activity and drawbacks with current systemic agents in myeloproliferative neoplasms.

Combinations May Confer Benefit in MDS Management

Combinations May Confer Benefit in MDS Management

Mikkael A. Sekeres, MD, discusses the characteristics of myelodysplastic syndrome and the evolving armamentarium of treatment.

Zonder Addresses Unanswered Questions in Newly Diagnosed Myeloma

Zonder Addresses Unanswered Questions in Newly Diagnosed Myeloma

Jeffrey A. Zonder, MD, discusses triplet regimens in multiple myeloma and patient eligibility for clinical trials.

OncLive SAP

FDA Approvals in HCC, RCC, and CLL, and ODAC Recommendations

Trending Now

Future Looks Bright for CAR T-Cell Therapies in Hematologic Malignancies

Treating Patients With CD30-Positive PTCL

Hepatocellular Carcinoma's Future Treatment Paradigm

Refinement of Techniques and the Future of mCRC

Covering Every Angle of Oncology Practice. Click a cover below, to view more.

Publication Bottom Border

Dermatologists in Cancer Care®

Milestones In Medicine

Priority Report

Pulmonologists in Cancer Care

Rapid Reviews in Oncology®

Urologists in Cancer Care

Oncology Business News

Contemporary Radiation Oncology

Oncology Nursing News

Oncology Fellows

Precision Medicine in Oncology

Invited Presentations

Oncology Treatment Pathways®

CURE Rare Cancers-Summer 2017 Issue

HEAL Summer 2017

Extraordinary Healers Vol. 11

Border Publication

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Oncology Nursing News
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc

OncLive Resources

Articles
Blogs
Conference Coverage
OncLive TV
Peer Exchange
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Forgot Password
Press Releases
Privacy Policy
Terms & Conditions

iTunes

YouTube

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.

x